Skip to content

BIO.BE: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BIO.BE

BE 0861.738.595
NACE 86.910, Medical imaging and medical laboratories
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€244,508
2024 · -€725,799+€481,291
Equity
€1.5m
2024 · €1.7m-€254,922
Cash
€157,624
2024 · €300,696-€143,072
Balance sheet total
€3.0m
2024 · €3.7m-€661,923

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€327,320

    down €327,320 (-32.2%), from €1.0m to €688,643

    of which Trade receivables: -€313,862

  • Tangible fixed assets -€145,292

    down €145,292 (-13.6%), from €1.1m to €924,475

  • Cash -€143,072

    down €143,072 (-47.6%), from €300,696 to €157,624

    mainly Other debts (-€375,450) and Net result for the year (-€244,508)

Equity and liabilities
  • Other debts -€375,450

    down €375,450 (-36.1%), from €1.0m to €663,982

  • Profit (loss) carried forward -€244,508

    down €244,508 (-139%), from -€176,171 to -€420,679

  • Trade debts +€151,746

    up €151,746 (+114%), from €133,408 to €285,154

  • Accrued charges and deferred income -€89,037

    down €89,037 (-79.4%), from €112,128 to €23,090

  • Debts after one year -€54,514

    down €54,514 (-11.5%), from €474,148 to €419,633

Income statement
  • Staff costs -€307,849

    down €307,849 (-37.5%), from €820,146 to €512,297

  • Other operating charges -€168,192

    down €168,192 (-89.2%), from €188,563 to €20,371

  • Write-downs +€83,954

    up €83,954, from -€83,144 to €810

  • Gross operating margin +€63,382

    up €63,382 (+14.3%), from €442,965 to €506,347

  • Depreciation -€47,053

    down €47,053 (-21.0%), from €223,583 to €176,530

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€725,799
Gross operating margin +€63,382
Staff costs +€307,849
Depreciation +€47,053
Write-downs -€83,954
Other operating charges +€168,192
Financial income +€7,842
Financial charges -€29,072
Result 2025 -€244,508
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€38,671
Investment -€15,154
Financing -€89,246
Cash 2024 €300,696
Net result for the year -€244,508
Depreciation +€176,530
Stocks and contracts +€11,328
Receivables within one year +€327,320
Deferred charges and accrued income +€18,828
Trade debts +€151,746
Tax, wage and social debts -€49,707
Advances received +€34,280
Other debts -€375,450
Accrued charges and deferred income -€89,037
Investment in fixed assets (net) -€15,154
Debts after one year -€54,514
Current portion of long-term debt +€1,265
Short-term financial debts -€25,583
Contributions, distributions and other -€10,414
Cash 2025 €157,624
brings cash intakes cash out
Every line side by side 56 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,700,279 €3,038,356 -€661,923 -17.9%
Fixed assets 21/28 €2,170,726 €2,009,350 -€161,376 -7.4%
Intangible fixed assets 21 €95,382 €64,144 -€31,238 -32.8%
Tangible fixed assets 22/27 €1,069,767 €924,475 -€145,292 -13.6%
Land and buildings 22 €947,398 €878,105 -€69,293 -7.3%
Plant, machinery and equipment 23 €103,718 €35,032 -€68,686 -66.2%
Furniture and vehicles 24 €18,651 €11,337 -€7,313 -39.2%
Financial fixed assets 28 €1,005,577 €1,020,731 +€15,154 +1.5%
Current assets 29/58 €1,529,553 €1,029,005 -€500,548 -32.7%
Stocks and contracts in progress 3 €77,184 €65,856 -€11,328 -14.7%
Stocks 30/36 €77,184 €65,856 -€11,328 -14.7%
Amounts receivable within one year 40/41 €1,015,963 €688,643 -€327,320 -32.2%
Trade receivables 40 €975,819 €661,957 -€313,862 -32.2%
Other amounts receivable 41 €40,144 €26,686 -€13,459 -33.5%
Cash at bank and in hand 54/58 €300,696 €157,624 -€143,072 -47.6%
Deferred charges and accrued income 490/1 €135,710 €116,882 -€18,828 -13.9%
Total equity and liabilities 10/49 €3,700,279 €3,038,356 -€661,923 -17.9%
Equity 10/15 €1,710,426 €1,455,504 -€254,922 -14.9%
Contributions 10/11 €1,591,250 €1,591,250 = 0.0%
Capital 10 €1,591,250 €1,591,250 = 0.0%
Issued capital 100 €1,591,250 €1,591,250 = 0.0%
Reserves 13 €159,125 €159,125 = 0.0%
Non-distributable reserves 130/1 €159,125 €159,125 = 0.0%
Legal reserve 130 €159,125 €159,125 = 0.0%
Profit (loss) carried forward 14 -€176,171 -€420,679 -€244,508 -139%
Investment grants 15 €136,222 €125,808 -€10,414 -7.6%
Amounts payable 17/49 €1,989,853 €1,582,852 -€407,001 -20.5%
Amounts payable after more than one year 17 €474,148 €419,633 -€54,514 -11.5%
Financial debts 170/4 €474,148 €419,633 -€54,514 -11.5%
Amounts payable within one year 42/48 €1,403,578 €1,140,128 -€263,450 -18.8%
Current portion of amounts payable after more than one year 42 €53,249 €54,514 +€1,265 +2.4%
Financial debts 43 €61,160 €35,577 -€25,583 -41.8%
Credit institutions 430/8 €61,160 €35,577 -€25,583 -41.8%
Trade debts 44 €133,408 €285,154 +€151,746 +114%
Suppliers 440/4 €133,408 €285,154 +€151,746 +114%
Advances received on contracts in progress 46 - €34,280 +€34,280
Taxes, remuneration and social security 45 €116,328 €66,621 -€49,707 -42.7%
Taxes 450/3 €23,906 €14,444 -€9,462 -39.6%
Remuneration and social security 454/9 €92,422 €52,177 -€40,245 -43.5%
Other amounts payable 47/48 €1,039,432 €663,982 -€375,450 -36.1%
Accrued charges and deferred income 492/3 €112,128 €23,090 -€89,037 -79.4%
Remuneration, social security and pensions 62 €820,146 €512,297 -€307,849 -37.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €223,583 €176,530 -€47,053 -21.0%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€83,144 €810 +€83,954
Other operating charges 640/8 €188,563 €20,371 -€168,192 -89.2%
Gross operating margin 9900 €442,965 €506,347 +€63,382 +14.3%
Operating profit (loss) 9901 -€706,182 -€203,662 +€502,521 +71.2%
Financial income 75/76B €17,726 €25,568 +€7,842 +44.2%
Recurring financial income 75 €17,726 €25,568 +€7,842 +44.2%
Non-recurring financial income 76B - €0 +€0
Financial charges 65/66B €37,343 €66,415 +€29,072 +77.9%
Recurring financial charges 65 €37,343 €66,415 +€29,072 +77.9%
Non-recurring financial charges 66B - €0 +€0
Profit (loss) for the period before taxes 9903 -€725,799 -€244,508 +€481,291 +66.3%
Profit (loss) for the period 9904 -€725,799 -€244,508 +€481,291 +66.3%
Profit (loss) for the period to be appropriated 9905 -€725,799 -€244,508 +€481,291 +66.3%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.